Pharmacoeconomic Evaluations of Pharmacogenetic and Genomic Screening Programmes

This publication has 58 references indexed in Scilit:

• Translating Pharmacogenomics: Challenges on the Road to the Clinic
  PLoS Medicine, 2007
• Pharmacoeconomic Analyses of Azathioprine, Methotrexate and Prospective Pharmacogenetic Testing for the Management of Inflammatory Bowel Disease
  PharmacoEconomics, 2006
• Gearing up for genome-wide gene-association studies
  Human Molecular Genetics, 2005
• A Cost-Effectiveness Analysis of Alternative Disease Management Strategies in Patients with Crohn's Disease Treated with Azathioprine or 6-Mercaptopurine
  American Journal of Gastroenterology, 2005
• Effect ofVKORC1Haplotypes on Transcriptional Regulation and Warfarin Dose
  New England Journal of Medicine, 2005
• Effect of Genetic Polymorphisms in Cytochrome P450 (CYP) 2C9 and CYP2C8 on the Pharmacokinetics of Oral Antidiabetic Drugs
  Clinical Pharmacokinetics, 2005
• Cost‐effectiveness of thiopurine methyltransferase genotype screening in patients about to commence azathioprine therapy for treatment of inflammatory bowel disease
  Alimentary Pharmacology & Therapeutics, 2004
• Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
  New England Journal of Medicine, 2004
• Pharmacoeconomic analysis of thiopurine methyltransferase polymorphism screening by polymerase chain reaction for treatment with azathioprine in Korea
  Rheumatology, 2003
• Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism
  Clinical Pharmacokinetics, 2002